Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

895
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
895
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.1K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complex emotion recognition in neurological and neurodevelopmental conditions.

Acta psychologica·2026
Same author

Social neuropsychology of epilepsy in the digital age: A narrative review on challenges and opportunities.

Epilepsy & behavior : E&B·2025
Same author

Recognition and perception of emotions in juvenile myoclonic epilepsy.

Epilepsia·2023
Same author

A comparative study of social cognition in epilepsy, brain injury, and Parkinson's disease.

PsyCh journal·2023
Same author

Digitally Assisted Standard Diagnostics in Insurance Medicine (DASDIM): psychometric data in psychiatric work disability evaluations.

Disability and rehabilitation·2022
Same author

Emotional Recognition in Patients With Mesial Temporal Epilepsy Associated With Enlarged Amygdala.

Frontiers in neurology·2022

Related Experiment Video

Updated: Mar 13, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K

Why epilepsy challenges social life.

Bettina K Steiger1, Hennric Jokeit2

  • 1Swiss Epilepsy Centre, Bleulerstrasse 60, CH-8008 Zurich, Switzerland; Psychological Institute, University of Zurich, Zurich, Switzerland.

Seizure
|October 21, 2016
PubMed
Summary

Social cognition deficits, including emotion recognition and theory of mind, impact social functioning in epilepsy. Addressing these socio-cognitive challenges is vital for improving quality of life for individuals with epilepsy.

Keywords:
Emotion recognitionQuality of lifeSocial cognitionSocial networkTemporal lobe epilepsyTheory of mind

More Related Videos

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

13.0K
Performing Behavioral Tasks in Subjects with Intracranial Electrodes
12:10

Performing Behavioral Tasks in Subjects with Intracranial Electrodes

Published on: October 2, 2014

11.9K

Related Experiment Videos

Last Updated: Mar 13, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

13.0K
Performing Behavioral Tasks in Subjects with Intracranial Electrodes
12:10

Performing Behavioral Tasks in Subjects with Intracranial Electrodes

Published on: October 2, 2014

11.9K

Area of Science:

  • Neuroscience
  • Psychology
  • Social Science

Background:

  • Social bonds are crucial for quality of life.
  • Epilepsy can impair cognitive and affective functions, hindering social interactions.
  • Psychological, psychiatric, and neuropsychological issues are common in epilepsy, affecting social information processing.

Purpose of the Study:

  • To examine societal, psychological, and neuropsychological factors influencing social life in epilepsy.
  • To emphasize socio-cognitive functions, particularly in temporal lobe epilepsy.
  • To highlight deficits in emotion recognition and theory of mind in mesial temporal lobe epilepsy.

Main Methods:

  • Review of behavioral studies on social cognition in epilepsy.
  • Focus on deficits in emotion recognition and theory of mind.
  • Discussion of diagnostic tool limitations and future research directions.

Main Results:

  • Individuals with mesial temporal lobe epilepsy frequently exhibit deficits in emotion recognition and theory of mind.
  • These socio-cognitive deficits have significant implications for patients' daily social functioning.
  • Current diagnostic tools may have limitations in assessing these social cognition aspects.

Conclusions:

  • Social cognition is a critical, yet often overlooked, component of comprehensive epilepsy care.
  • Understanding individual and interpersonal determinants of social functioning is essential.
  • Future research should focus on integrating social cognition assessment into epilepsy management.